Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 7INDUSTRY 7NETWORK 2FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 9Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 4Carcinoma, Hepatocellular 3Non-Muscle Invasive Bladder Neoplasms 2Neoplasms by Site 2Esophageal Squamous Cell Carcinoma 2Adenocarcinoma Of Esophagus 2Urogenital Neoplasms 1Tobacco Use Disorder 1Tobacco Use 1Thoracic Neoplasms 1Substance-Related Disorders 1Small Cell Lung Carcinoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pain, Postoperative 1Opioid-Related Disorders 1Neoplasm Metastasis 1Motor Activity 1Male Urogenital Diseases 1Lymphoma 1Lung Diseases 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Imipramine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × FED × Keratosis, Actinic × Clear all
NCT06778434 2025-12-22

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

VA Office of Research and Development

Phase 2 Recruiting
48 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡